Moolec Science Presents 'Piggy Sooy', a Soybean Platform That Can Produce Significantly High Amounts of Pork Proteins
Luxembourg, Jun 27, 2023 - (ACN Newswire) - Moolec Science SA ((NASDAQ:MLEC) "Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today an outstanding achievement in its Meat Replacements Program for the Soybean platform, as its new "Piggy Sooy" produced a significantly high amount of pork protein.
 | Piggy Sooy |
The animal protein reached a high expression level up to 26.6% of total soluble protein in soy seeds, 4x higher than initially projected by the Company. The result can be directly observed due to the pink color of Moolec's soybeans, the same color as the pig (access the picture by clicking here https://moolecscience.com/#piggysooy ). After this achievement, the Company's soybean platform was renamed "Piggy Sooy".
The breakthrough accomplishment has led Moolec to file a new patent utilizing a novel approach aiming to provide the Company with a frictionless regulatory pathway going forward.
Moolec's CEO & Co-Founder Gaston Paladini said: "Piggy Sooy represents tangible and visual proof that Moolec's technology has the capacity to achieve significant yields in plants to produce meat proteins. With this groundbreaking achievement, Moolec consolidates its position as a category creator and a pioneer in Molecular Farming for the food industry. Our plant biology team is writing the history of science in food, I couldn't be prouder of them."
This scientific milestone consolidates the Molecular Farming path as one of the most valuable alternative technologies to produce animal proteins, given that plants can function as animal protein factories in a more efficient manner than initially expected. This enhanced efficiency of plants has the potential to improve the economics of the Company's business model.
Moolec Science is producing several meat proteins in plants as functional ingredients to improve the taste, appearance, texture, and nutrition of meat alternatives. Due to its enhanced functionality and final application, the Company also highlighted that these food ingredients could also be potentially commercialized within the ~$600 billion traditional processing meat industry.
Amit Dhingra, Ph.D., Chief Science Officer of Moolec said: "This achievement opens up a precedent for the entire scientific community that is looking to achieve high levels of protein expression in seeds via Molecular Farming." He further emphasized: "Moolec has developed a unique, successful, and patentable platform for the expression of highly valuable proteins in the seeds of economically important crops such as soybeans. This platform has the potential to be used across a wide variety of proteins of interest for a broad range of industries, such as the pharma, cosmetic, diagnostic reagents, and other food industries."
About Moolec Science SA
Moolec is a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The Company's technological approach aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company's product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like safflower, soybean, and pea. Moolec has a growing international patent portfolio (24, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit moolecscience.com.
Forward-Looking Statements
This press release contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in the Moolec' Annual Report on Form 20-Filled with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.
Contact Information Catalina Jones Chief of Staff & Sustainability comms@moolecscience.com
Martin Taraciuk Investor Relations ir@moolecscience.com
Michael Bowen ICR, LLC moolecir@icrinc.com
Edmond Lococo ICR edmond.lococo@icrinc.com
Related Files Moolec Science Presents "Piggy Sooy", A Soybean Platform That Can Produce Significantly High Amounts Of Pork Proteins.pdf https://cdn.newswire.com/files/x/d9/db/f425d1320c1028c17fdceea2e8f4.pdf
Source: Moolec Science SA Sectors: Agritech, Food & Beverage
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Approval in Principle (AiP) for the Basic Design of a Large Ammonia-Fueled Ammonia Carrier Obtained from Classification Society Mar 14, 2025 18:37 JST
|  Toyota Launches All-New Crown Estate in Japan Mar 14, 2025 17:22 JST
|  Hokkaido Electric Power Corporation and Mitsubishi Corporation Establish a Joint Venture "Hokkaido Renewable Energy Aggregation Co., Ltd." Mar 13, 2025 13:26 JST
|  Lexus Presents the World Premiere of the New "RZ" Mar 12, 2025 17:45 JST
|  MHIET Achieves Rated Operation of a 6-Cylinder 500kW-class Hydrogen Engine Generator Set Mar 12, 2025 14:11 JST
|  MOL and Fujitsu leverage AI for efficient crew replacement planning Mar 12, 2025 13:53 JST
|  TANAKA PRECIOUS METAL TECHNOLOGIES Develops Miniaturized Micro Profile, a Next-Generation Contact tape for Fifth-Generation Signal Relays Mar 12, 2025 11:00 JST
|  JCB Now Available on Google Play in Thailand, Indonesia, Vietnam, Philippines, and Hong Kong Mar 12, 2025 11:00 JST
|  JCB Announced Premier Sponsorship for the 10th Edition of Sakura 2025 at Singapore's Gardens by the Bay Mar 11, 2025 18:00 JST
|  Hitachi Energy invests additional $250 million USD to address global transformer shortage Mar 11, 2025 17:49 JST
|  Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time Mar 10, 2025 20:24 JST
|  CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI Mar 10, 2025 12:10 JST
|  Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels Mar 07, 2025 16:24 JST
|  NEC improves the energy efficiency and floor space density of 5G Mobile Core systems Mar 06, 2025 13:20 JST
|  Unmanned Aerial Vehicles Being Developed by MHI Used in Demonstration of Automated Transport and Unloading of Heavy Cargo in Disaster Areas Mar 05, 2025 16:11 JST
|  Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan Mar 05, 2025 09:09 JST
|  MHI-MS Completes Domestic Development of Vehicle Transport Robot Mar 04, 2025 19:39 JST
|  Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia Mar 04, 2025 17:22 JST
|  Prideone Entertainment announces concept for post-war film to mark 80th anniversary of the end of World War II Mar 04, 2025 16:00 JST
|  NTT and DOCOMO Successfully Demonstrates On-Demand Unified Control of Computing Services Through Network and Service Integration Mar 03, 2025 20:25 JST
|
More Latest Release >>
|